Home/Ona Therapeutics/Mercè de Frias, PhD, MBA
MD

Mercè de Frias, PhD, MBA

Chief Operating Officer

Ona Therapeutics

Therapeutic Areas

Ona Therapeutics Pipeline

DrugIndicationPhase
ONA-255Refractory Breast Cancer and Solid TumorsPre-clinical
ONA-389Prevalent Solid TumorsPre-clinical